Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 14 Nov 2024 for HCA Healthcare, Inc., €1.3M. Read the official filing
Filing timeline
BuySaleErol R. Akdamar
Insider track record
Disclosed buys
0
Disclosed sells
2
Signal history
Erol R. Akdamar: trading record in brief
Erol R. Akdamar is a declared insider of HCA Healthcare, Inc., with filings sourced from SEC (Form 4). In total, 10 filings cover trades dated from 2 February 2023 to 12 November 2024.
Sales make up the whole of the open-market record (2 sales, €1.6M). Outside the open market, there are 2 share grants and 2 option exercises.
Most recently, on 14 November 2024, the filings show an option exercise worth €1.3M in HCA Healthcare, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Erol R. Akdamar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
20,000 shares@ US$68.9631.5% of flowCommon StockSEC:0000950170-24-127310:0
5,139 shares0Common StockSEC:0001209191-24-005625:0
7,700 shares0Common StockSEC:0001209191-24-003738:0
12,874 shares0Common StockSEC:0001209191-24-003002:0
26,825 shares@ US$47.9729.3% of flowCommon StockSEC:0001209191-23-055408:0
3,500 shares@ US$285.0022.0% of flowCommon StockSEC:0001209191-23-026608:0
42,484 shares0Common StockSEC:0001209191-23-026608:1
42,484 shares0Common StockSEC:0001209191-23-026608:2
9,300 shares0Common StockSEC:0001209191-23-011970:0
3,000 shares@ US$258.630417.2% of flowCommon StockSEC:0001209191-23-007354:0
10 of 10 declarations
